Viewing StudyNCT00205842



Ignite Creation Date: 2024-05-05 @ 12:00 PM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00205842
Status: COMPLETED
Last Update Posted: 2016-01-11
First Post: 2005-09-13

Brief Title: Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel DysfunctionPostoperative Ileus
Sponsor: Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization: Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-06
Start Date Type: None
Primary Completion Date: 2005-12
Primary Completion Date Type: ACTUAL
Completion Date: 2005-12
Completion Date Type: ACTUAL
First Submit Date: 2005-09-13
First Submit QC Date: September 13 2005
Study First Post Date: 2005-09-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-01-07
Last Update Post Date: 2016-01-11
Last Update Post Date Type: ESTIMATED